The technologies and techniques developed for eye transplantation and nerve regeneration may have significant translational potential for other biomedical needs including: spinal cord injury, central nervous system regeneration, retinal cell and tissue transplantation, and other forms of organ and tissue transplantation.
The U.S. district attorney for Massachusetts filed suit against the drugmaker this week, alleging that it paid tens of millions in kickbacks through a copay foundation for Eylea, a drug used to treat macular degeneration.
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
The company has signed an initial partnership with Genentech that will focus on understanding the genetic components that are related to a person's risk of developing ocular diseases like macular degeneration.
The company's technology for screening diabetic retinopathy was granted "Breakthrough Device" designation and is able to provide a clinical decision, instead of simply a recommendation to the physician.
The analysis said that the consent forms signed by the women did not mention a clinical trial.
Clearside Biomedical will use the Series C round to further clinical trials for its drug-device combination for diseases of the eye that cause blindness.
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
One of the most commonly prescribed drugs for wet age-related macular degeneration is Avastin – a cancer drug. So it’s not that surprising that a new approach for wet AMD is radiation therapy – with aims to halt the growth of the unruly blood vessels that cause the disease. Arizona startup Salutaris Medical Devices is developing a device […]
Researchers have been exploring the potential of laser light therapy in a number of disease states for quite a while. Poulsbo, Washington startup LumiThera is developing an LED light-based instrument, for use in an ophthalmologist’s office, to treat the dry form of acute macular degeneration. The company uses low-level light therapy, or LLLT, in which patients are […]
Rather than using injections to deliver treatments to the middle and back of the eye, Kala Pharmaceuticals might have a way to get them there with topical drops. The Massachusetts-based company is developing eye drops designed to carry drugs through the layer of mucus on the eye’s surface — a barrier that typically gets in […]
With an aging population and rising rates of vision loss, the U.S. pharmaceutical and medical device industries have latched onto ophthalmology as an area where innovation is both needed and lucrative. Cleveland-area startup Visum Therapeutics is one of the companies going after an orphan eye disease called Stargardt disease, which is a juvenile manifestation of […]
A cure for spinal cord injury? Diabetes? Macular degeneration? Hope or just hype? There are now some clinical trials using embryonic stem cells to treat serious diseases for which no other good therapy is currently available. But this is just the beginning of a major medical megatrend that will blossom forth in the coming years. […]